[ET Net News Agency, 29 June 2021] Daiwa lowered its target price for Shanghai Junshi
Biosciences (01877) to HK$85 from HK$90 and maintained its "buy" rating.
The research house said its new TP reflects its more conservative revenue forecasts for
JS016 in view of the distribution pause, a rise in operating expense, and update of its
innovative pipeline. (RC)